Erasca, Inc.
3115 Merryfield Row, Suite 300
San Diego, CA 92121
May 14, 2024
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
| Re: | Erasca, Inc. |
Registration Statement on Form S-3
File No. 333-279261
To the addressees set forth above:
Pursuant to Rule 461 of Regulation C of the General Rules and Regulations under the Securities Act of 1933, as amended, the undersigned, on behalf of Erasca, Inc., respectfully requests that the effective date of the Registration Statement on Form S-3 referred to above be accelerated so that it will become effective at 4:00 P.M. Eastern Time on May 16, 2024, or as soon as practicable thereafter.
If you have any questions or require additional information, please contact Matthew T. Bush, Esq. of Latham & Watkins LLP at (858) 523-3962. Thank you for your assistance and cooperation in this matter.
| Very truly yours, | ||
| ERASCA, INC. | ||
| By: | /s/ Jonathan E. Lim | |
| Jonathan E. Lim, M.D. | ||
| Chairman, Chief Executive Officer and Co-Founder | ||
| cc: | Ebun S. Garner, Erasca, Inc. |
Cheston J. Larson, Latham & Watkins LLP
Matthew T. Bush, Latham & Watkins LLP